» Articles » PMID: 39925462

Network Pharmacology and in Silico Approach to Study the Mechanism of Quercetin Against Breast Cancer

Overview
Date 2025 Feb 10
PMID 39925462
Authors
Affiliations
Soon will be listed here.
Abstract

Graphical Abstract:

References
1.
Basu A, Lambring C . Akt Isoforms: A Family Affair in Breast Cancer. Cancers (Basel). 2021; 13(14). PMC: 8306188. DOI: 10.3390/cancers13143445. View

2.
Sticova E, Jirsa M . ABCB4 disease: Many faces of one gene deficiency. Ann Hepatol. 2019; 19(2):126-133. DOI: 10.1016/j.aohep.2019.09.010. View

3.
He Q, Liu C, Wang X, Rong K, Zhu M, Duan L . Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking. Front Pharmacol. 2023; 14:1102581. PMC: 9975159. DOI: 10.3389/fphar.2023.1102581. View

4.
Ezzati M, Yousefi B, Velaei K, Safa A . A review on anti-cancer properties of Quercetin in breast cancer. Life Sci. 2020; 248:117463. DOI: 10.1016/j.lfs.2020.117463. View

5.
Yang L, Hu Z, Zhu J, Liang Q, Zhou H, Li J . Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach. Biomed Res Int. 2020; 2020:3860213. PMC: 7486643. DOI: 10.1155/2020/3860213. View